Cubist Pharmaceuticals Inc. CBST

Full chart Compare
Set alert

Price alert · CBST

All alert types
101.94 0.00 (+0.00%)

At closeJun 28, 2019, 6:07 PM EDT

101.94 Day range 101.99
58.50 52-week range 101.99

Revenue & Expenses

Income Tax Benefit → Expenses: $25.07MExpenses → Selling, General & Admin: $257.94MExpenses → Research & Development: $477.74MExpenses → Other Operating Expenses: $32.04MExpenses → Interest Expense: $37.60MExpenses → Other Expenses: $32.45MGross Profit → Expenses: $794.13MRevenue → Gross Profit: $794.13MRevenue → Cost of Revenue: $260.31MNet Loss → Expenses: $18.57MIncome Tax Benefit$25.07MGross Profit$794.13MNet Loss$18.57MCost of Revenue$260.31MExpenses$837.78MSelling, General & Admin$257.94MResearch & Development$477.74MOther Operating Expenses$32.04MInterest Expense$37.60MOther Expenses$32.45MRevenue$1.05B

Latest period ending Dec 31, 2013 · select a line to chart its full history

CBST annual income statement
Fiscal yearFY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010FY 2009 Dec 31, 2009
1.05B926.36M753.97M636.46M562.14M
794.13M696.30M581.11M495.69M445.25M
26.41M237.11M132.53M189.60M137.76M
-18.57M154.07M33.02M94.33M79.60M
-0.272.100.521.551.36
CBST annual balance sheet
Fiscal yearFY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010FY 2009 Dec 31, 2009
91.06M104.04M197.62M372.97M157.32M
3.15B1.93B1.88B1.42B983.68M
1.75B941.64M1.08B751.73M513.04M
817.83M367.81M454.25M435.80M245.39M
1.39B990.75M799.86M663.42M470.64M
CBST annual cash flow
Fiscal yearFY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010FY 2009 Dec 31, 2009
16.41M215.65M200.37M184.47M159.76M
-787.63M-232.42M-439.55M-222.70M-416.22M
758.16M-76.81M62.84M252.99M4.98M
-15.51M-18.13M-100.07M-17.47M-11.11M
-13.06M-93.58M-176.34M214.76M-251.47M